Subject(s)
Bradycardia/diagnosis , Coronary Stenosis/diagnostic imaging , Coronary Vasospasm/diagnosis , Plaque, Atherosclerotic/diagnostic imaging , Syncope/etiology , Adult , Bradycardia/etiology , Coronary Angiography , Coronary Stenosis/complications , Coronary Vasospasm/complications , Electrocardiography , Humans , Male , Plaque, Atherosclerotic/complicationsABSTRACT
PURPOSE: Acute pericarditis is a minor complication following atrial fibrillation (AF) ablation procedures. The aim of the study was to evaluate the incidence and clinical aspects of pericarditis following cryoballoon (CB) ablation of AF investigating a possible association with procedural characteristics and a possible relationship with post-ablation recurrences. METHODS: Four hundred fifty consecutive patients (male 73%, age 59.9 ± 11.2 years) with drug-resistant paroxysmal AF who underwent CB ablation as index procedure were enrolled. Exclusion criteria were any contraindication for the procedure including the presence of intracavitary thrombus and uncontrolled heart failure and contraindications to general anesthesia. RESULTS: Acute pericarditis following CB ablation occurred in 18 patients (4%) of our study population. Pericardial effusion occurred in 14 patients (78%) and was mild/moderate. The total number of cryoapplications and the total freeze duration were significantly higher in patients with pericarditis compared with those without (respectively, p = 0.0006 and p = 0.01). Specifically, the number of applications and freeze duration in right inferior pulmonary vein were found significantly higher in patients with pericarditis (p = 0.007). The recurrence rate did not significantly differ between the two study groups (respectively, 16.7 vs 18.1%; p = 0.9). CONCLUSIONS: The incidence of acute pericarditis following CB ablation in our study population accounted for 4% and was associated with both total freezing time and number of cryoapplications. The clinical course was favorable in all these patients and the occurrence of acute pericarditis did not affect the outcome during the follow-up period.
Subject(s)
Atrial Fibrillation/surgery , Catheter Ablation/adverse effects , Cryosurgery/adverse effects , Pericarditis/etiology , Pulmonary Veins/surgery , Acute Disease , Aged , Atrial Fibrillation/diagnostic imaging , Catheter Ablation/methods , Cohort Studies , Cryosurgery/methods , Electrocardiography/methods , Female , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Pericarditis/epidemiology , Pericarditis/physiopathology , Postoperative Complications/diagnosis , Postoperative Complications/epidemiology , Postoperative Complications/therapy , Recurrence , Retrospective Studies , Risk Assessment , Time Factors , Treatment OutcomeSubject(s)
Atrial Fibrillation/therapy , Catheter Ablation/adverse effects , Coronary Artery Bypass , Cryosurgery/adverse effects , Pulmonary Veins/surgery , ST Elevation Myocardial Infarction/etiology , Aged , Atrial Fibrillation/diagnosis , Atrial Fibrillation/physiopathology , Cardiac Catheters , Catheter Ablation/instrumentation , Cryosurgery/instrumentation , Female , Humans , Pulmonary Veins/physiopathology , Risk Factors , ST Elevation Myocardial Infarction/diagnostic imaging , Tomography, X-Ray ComputedABSTRACT
Cardiac resynchronization therapy (CRT) is a novel and effective therapy for patients with heart failure. The aim of CRT is to improve the heart's pumping efficiency by the resynchronization of the chambers. Electrical dyssynchrony shows itself as bundle branch block with prolongation of QRS >120 ms. Mechanical dyssynchrony (atrioventricular, interventricular and intraventricular) is evidenced by echocardiographic parameters. A cardioverter-defibrillator function can be included with the pulse generator in patients with high risk of sudden death. The estimate of perioperative death associated with CRT was 0.3% with a low rate of complications, similar to that seen in standard pacemaker placement. In 10% of patients there was an implant failure due to the difficulty in accessing the coronary sinus. Approximately one third of patients are non-responder with no significant improvement after implantation. The beneficial effect of CRT on soft endpoints and mortality (symptoms, NYHA class, 6-min walking test, quality of life score, ejection fraction) was demonstrated in the earliest randomized clinical trials. Current guidelines for CRT are based on inclusion and exclusion criteria in the large randomized trials that have been performed and patients with chronic atrial fibrillation are included. Unresolved issues are the identification of non-responders and the efficacy of CRT in patients with mechanical dyssynchrony without electrical dyssynchrony and in NYHA functional class I/II patients with ejection fraction < or = 35%.